UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery

Peptides (New York, N.Y. : 1980), 2010-01, Vol.31 (1), p.184-193

2010

Volltextzugriff (PDF)

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

British journal of cancer, 2011-11, Vol.105 (10), p.1503-1511

2011

Volltextzugriff (PDF)

Effect of Deoxyribozymes Targeting c-Jun on Solid Tumor Growth and Angiogenesis in Rodents

JNCI : Journal of the National Cancer Institute, 2004-05, Vol.96 (9), p.683-696

2004

Volltextzugriff (PDF)

Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis

Cancer gene therapy, 2007-07, Vol.14 (7), p.616-626

2007

Volltextzugriff (PDF)

Angiogenesis Inhibitors and the Need for Anti-angiogenic Therapeutics

Journal of Dental Research, 2007-10, Vol.86 (10), p.927-936

2007

Volltextzugriff (PDF)

Development of chondrosarcoma animal models for assessment of adjuvant therapy

ANZ journal of surgery, 2009-05, Vol.79 (5), p.327-336

2009

Volltextzugriff (PDF)

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical

Pharmazie, 2016-04, Vol.71 (4), p.171-174

2016

Volltextzugriff (PDF)

Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation

Pharmazie, 2012-12, Vol.67 (12), p.1010-1014

2012

Volltextzugriff (PDF)

Treatment of bone disorders with parathyroid hormone: success and pitfalls

Pharmazie, 2016-08, Vol.71 (8), p.427-433

2016

Volltextzugriff (PDF)

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: evidence in silico, in vitro and in vivo

Pharmazie, 2016-07, Vol.71 (7), p.382-389

2016

Volltextzugriff (PDF)

Apolipoprotein A-I, Cyclodextrins and Liposomes as Potential Drugs for the Reversal of Atherosclerosis. A Review

Journal of pharmacy and pharmacology, 2000-07, Vol.52 (7), p.731-761

2000

Volltextzugriff (PDF)

Current and future treatments of bone metastases

Expert opinion on emerging drugs, 2008-12, Vol.13 (4), p.609-627

2008

Volltextzugriff (PDF)

The pathophysiological role of PEDF in bone diseases

Current molecular medicine, 2010-04, Vol.10 (3), p.296-301

2010

Volltextzugriff (PDF)

Immunostimulatory activity of cationic-lipid-nucleic-acid complexes against cancer

Journal of cancer research and clinical oncology, 2002-04, Vol.128 (4), p.177-181

DASS, C. R

2002

Volltextzugriff (PDF)

Delivery of Lipoplexes for Genotherapy of Solid Tumours: Role of Vascular Endothelial Cells

Journal of pharmacy and pharmacology, 2000-11, Vol.52 (11), p.1301-1317

2000

Volltextzugriff (PDF)

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy

Pharmazie, 2010-12, Vol.65 (12), p.855-859

2010

Volltextzugriff (PDF)

Lipoplexes and Tumours. A Review

Journal of pharmacy and pharmacology, 1999-07, Vol.51 (7), p.755-770

1999

Volltextzugriff (PDF)

Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo

Journal of pharmacy and pharmacology, 2002-05, Vol.54 (5), p.593-601

Dass, Crispin R.

2002

Volltextzugriff (PDF)

Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotides

Anticancer research, 2002-07, Vol.22 (4), p.2237

2002

Volltextzugriff (PDF)

Vehicles for oligonucleotide delivery to tumours

Journal of pharmacy and pharmacology, 2002-01, Vol.54 (1), p.3-27

Dass, Crispin R.

2002

Volltextzugriff (PDF)

Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature

International Journal of Pharmaceutics, 2003-11, Vol.267 (1), p.1-12

Dass, Crispin R.

2003

Volltextzugriff (PDF)

Breast cancer bone metastases: pathogenesis and therapeutic targets

The international journal of biochemistry & cell biology, 2018-03, Vol.96, p.63-78

2018

Volltextzugriff (PDF)

C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies

Pharmazie, 2008-06, Vol.63 (6), p.411-414

2008

Volltextzugriff (PDF)

Enhanced Anticancer Therapy Mediated by Specialized Liposomes

Journal of pharmacy and pharmacology, 1997-10, Vol.49 (10), p.972-975

1997

Volltextzugriff (PDF)

A Method for Intratumoral Continuous Infusion of Antisense Oligodeoxynucleotides

Journal of pharmaceutical sciences, 1998-03, Vol.87 (3), p.387-389

1998

Volltextzugriff (PDF)

1 – 25 von 298

Menü

Weitere Dienste

Einstellungen

Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model

Effect of Deoxyribozymes Targeting c-Jun on Solid Tumor Growth and Angiogenesis in Rodents

Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis

Angiogenesis Inhibitors and the Need for Anti-angiogenic Therapeutics

Development of chondrosarcoma animal models for assessment of adjuvant therapy

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical

Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation

Treatment of bone disorders with parathyroid hormone: success and pitfalls

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: evidence in silico, in vitro and in vivo

Apolipoprotein A-I, Cyclodextrins and Liposomes as Potential Drugs for the Reversal of Atherosclerosis. A Review

Current and future treatments of bone metastases

The pathophysiological role of PEDF in bone diseases

Immunostimulatory activity of cationic-lipid-nucleic-acid complexes against cancer

Delivery of Lipoplexes for Genotherapy of Solid Tumours: Role of Vascular Endothelial Cells

Delivery of nanoparticulate drug delivery systems via the intravenous route for cancer gene therapy

Lipoplexes and Tumours. A Review

Cytotoxicity issues pertinent to lipoplex-mediated gene therapy in-vivo

Enhanced in vivo tumour response from combination of carboplatin and low-dose c-myc antisense oligonucleotides

Vehicles for oligonucleotide delivery to tumours

Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature

Breast cancer bone metastases: pathogenesis and therapeutic targets

C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies

Enhanced Anticancer Therapy Mediated by Specialized Liposomes

A Method for Intratumoral Continuous Infusion of Antisense Oligodeoxynucleotides

Suchergebnisse filtern